Smith Breast Center at Baylor College of Medicine Evaluates OpenClinica for Enterprise-wide Use

Akaza Research and the Lester and Sue Smith Breast Center at the Baylor College of Medicine collaborate to determine the feasibility of using OpenClinica on an institution-wide basis for clinical studies.

Cambridge, Massachusetts (PRWEB) October 2, 2007 -- Akaza Research, the leading provider of OpenClinica clinical trials software, and the Lester and Sue Smith Breast Center at the Baylor College of Medicine, are collaborating to determine the feasibility of using OpenClinica on an institution-wide basis for clinical studies.

"OpenClinica's open source and standards-based approach makes it a good choice for use across our institution's heterogeneous research environment," said Pam Mayfield, Programmer Analyst at Baylor. "For example, we seek to integrate OpenClinica with our existing applications and workflows, and extend the system based on emerging standards such as CDISC and caBIG," she added.

As part of the relationship Akaza will provide implementation and ongoing support and maintenance for OpenClinica at the Smith Breast Center. In addition, Akaza will assist Baylor College of Medicine in a collaborative process of assessing user needs and designing solutions to meet those needs.

Baylor College of Medicine will apply OpenClinica as a component of their suite of clinical research tools while integrating the software to work on top of their existing authentication systems and databases.

About the Smith Breast Center:

The mission of the Lester and Sue Smith Breast Center at Baylor College of Medicine is to improve the diagnosis and treatment of women with breast disease through comprehensive, high quality, and efficient clinical care, basic, translational, and clinical research, as well as education of physicians, laboratory scientists, and ancillary personnel. The Breast Research Program is one of only ten recipients nationally of the NIH Specialized Program of Research Excellence (SPORE) Grant in Breast Cancer, which highlights the accomplishments and productivity of the program. For more information visit http://www.breastcenter.tmc.edu/

About OpenClinica®:

OpenClinica is open source web-based electronic data capture software for clinical research. It facilitates protocol configuration, design of case report forms, clinical data capture, and study/data management. OpenClinica supports HIPAA and 21 CFR Part 11 guidelines and is designed as a lightweight, standards-based, extensible, and modular platform. The current production release of OpenClinica is version 2.0.1. All versions of OpenClinica are available for download at www.OpenClinica.org.

About Akaza Research®:

Akaza Research, the leading provider of open source clinical trial software, is headquartered in Cambridge, Massachusetts. Supported by the National Institutes of Health (NIH), Akaza has developed and commercialized OpenClinica, the preeminent open source clinical trial data capture and management software platform. Akaza brings Open Source Software (OSS) into the mainstream of the clinical research enterprise by making robust, flexible, standards-based systems accessible for private and public research. Akaza Research provides OpenClinica support, training, and consulting services to its customers worldwide. See www.akazaresearch.com.

###

Suggested Articles

After delivering a "positive surprise" in December, Biogen is painting a fuller picture of its lupus drug.

A new CRISPR technique neutralizes SARS-CoV-2 by scrambling the virus' genetic code. It could prove useful for fighting other viruses, like influenza.

The deal, which follows a bidding war with AcelRx, gives Melinta another approved antibiotic and potentially complementary R&D expertise.